Merck/Bayer's Vericiguat Could Bring A New Dynamic For Heart Failure

Autumn red leaf with cut heart in a hand - Image
Vericiguat helped certain patients with chronic heart failure in a Phase III study • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Archive

More from Scrip